From: Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Score | Before | After | Z | P |
---|---|---|---|---|
APRI: | − 2.828 | 0.005 | ||
< 0.5 0.5–1.5 >1.5 | 16 (47.1%) 16 (47.1%) 2 (5.9%) | 22 (64.7%) 12 (35.3%) 0 (0%) | ||
FIB4: | − 1.633 | 0.102 | ||
< 1.45 1.45–3.25 > 3.25 | 14 (41.2%) 15 (44.1%) 5 (14.7%) | 16 (47.1%) 15 (44.1%) 3 (8.8%) |